Filing Details
- Accession Number:
- 0001104659-15-062764
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-31 16:31:06
- Reporting Period:
- 2015-08-27
- Filing Date:
- 2015-08-31
- Accepted Time:
- 2015-08-31 16:31:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1157602 | Vitae Pharmaceuticals Inc | VTAE | Pharmaceutical Preparations (2834) | 043567753 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1598129 | Arthur Fratamico | C/O Vitae Pharmaceuticals, Inc. 502 West Office Center Dr. Fort Washington PA 19034 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-08-27 | 10,000 | $7.83 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.735 to $7.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
Billionaire Hedge Funds
